AI summary is being generated. Check back soon for a plain-language breakdown of this bill.
Positive media analysis is being generated.
Critical media analysis is being generated.
Senator Todd Gardenhire's sponsorship of SB0254 presents potential conflicts of interest due to his personal financial interests in the pharmaceutical industry. Specifically, he holds assets in Pfizer and Eli Lilly & Co, both of which are involved in pharmaceuticals and health products. The bill mandates that defendants pay for the costs associated with monitoring devices, which could lead to increased demand for pharmaceutical products related to substance abuse monitoring and treatment. This creates a direct financial interest for the sponsor, as any increase in the use of such monitoring devices could indirectly benefit the pharmaceutical companies he is invested in.
Additionally, the bill's implications for drug safety and monitoring could further intertwine with the interests of these pharmaceutical companies, potentially leading to a situation where the sponsor's financial interests may influence his legislative decisions. Given the direct alignment of his personal investments with the bill's subject matter, there is a significant risk that his financial interests could conflict with the public interest in ensuring fair and equitable treatment under the law.
Unlike federal analysis based on campaign donations, state analysis examines legislators' personal financial interests — their jobs, businesses, and investments.
| Type | Description | Industry | Source |
|---|---|---|---|
| Occupation | Financial Advisor | — | AI-researched |
| Employer | Retired from Morgan Stanley | Securities & Investment | TN Legislature bio |
| Board Member | Board member of the Tennessee Student Assistance Corporation | — | TN Legislature bio |
| Spouse Employer | INTERNATIONAL BUSINESS MACHINE PENSION ANNUITY | — | TN Ethics Commission |
| Employer | METLIFE PENSION ANNUITY | — | TN Ethics Commission |
| Employer | SOCIAL SECURITY | — | TN Ethics Commission |
| Employer | SEP IRA RMD | — | TN Ethics Commission |
| Employer | MORGAN STANLEY COMMON STOCK | Securities & Investment | TN Ethics Commission |
| Asset | MORGAN STANLEY COMMON | Securities & Investment | TN Ethics Commission |
| Asset | BROWN CAPITAL SMALL CAP | — | TN Ethics Commission |
| Asset | JANUS HENDERSON ENTERPRISE N | — | TN Ethics Commission |
| Asset | ALLIANZ NFJ LARGE CAP VALUE | — | TN Ethics Commission |
| Asset | NATIONAL HEALTHCARE CORP | — | TN Ethics Commission |
| Asset | SPROTT PHYSICAL GOLD TRUST | — | TN Ethics Commission |
| Asset | CUSIP 9128285T3 | — | TN Ethics Commission |
| Asset | CUSIP 912828XZ8 | — | TN Ethics Commission |
| Asset | CUSIP 91282CEU1 | — | TN Ethics Commission |
| Asset | CUSIP 91282CFP1 | — | TN Ethics Commission |
| Asset | FIFTH 3D BANCORP | — | TN Ethics Commission |
| Asset | FIRST HORIZON CORP | — | TN Ethics Commission |
| Asset | REGIONS FINANCIAL | — | TN Ethics Commission |
| Asset | ASTEC INC. | — | TN Ethics Commission |
| Asset | SANOFI | — | TN Ethics Commission |
| Asset | PFIZER | Pharmaceuticals/Health Products | TN Ethics Commission |
| Asset | ELI LILLY & CO | Pharmaceuticals/Health Products | TN Ethics Commission |
| Asset | BRISTOL MYERS SQUIBB & CO | — | TN Ethics Commission |
| Asset | ASTRAZENECA PLC ADR | — | TN Ethics Commission |
| Asset | EXXON MOBIL | Oil & Gas | TN Ethics Commission |
Items marked "AI-researched" are generated from public sources but have not been independently verified. Verified data is sourced from official legislature websites and disclosure filings.
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Tennessee General Assembly. Conflict analysis examines the sponsor's personal financial interests for potential overlaps with the bill's subject matter.
TN SB0254